A PYMNTS Company

US: Cardinal health to pay $26.8 million to settle monopoly charges

By  |  April 20, 2015

Cardinal Health has agreed to pay $26.8 million to settle charges it illegally monopolized markets in 25 cities for the sale of low-energy radiopharmaceuticals to hospitals and clinics, the Federal Trade Commission said on Monday.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The FTC accused Cardinal, which became the biggest U.S. operator of radiopharmacies through acquisitions in 2003 and 2004, of pressuring companies that make radiopharmaceuticals used in heart stress tests to refuse to sell to Cardinal’s rivals in the 25 U.S. cities.

     

    Full Content: The New York Times

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.